obovatol has been researched along with Colonic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, JS; Han, SB; Hong, JT; Jung, JK; Lee, SY; Lee, YM; Moon, DC; Oh, KW; Yoo, HS; Yuk, DY | 1 |
| Hong, JT; Jung, JK; Lee, BS; Lee, SY; Moon, DC; Song, HS; Yoon, DY; Yuk, DY | 1 |
2 other study(ies) available for obovatol and Colonic Neoplasms
| Article | Year |
|---|---|
Obovatol enhances docetaxel-induced prostate and colon cancer cell death through inactivation of nuclear transcription factor-kappaB.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Biphenyl Compounds; Cell Death; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Colonic Neoplasms; Docetaxel; Drug Synergism; Fluorescent Dyes; HCT116 Cells; Humans; In Situ Nick-End Labeling; Indoles; Inhibitory Concentration 50; Magnolia; Male; Molecular Structure; NF-kappa B; Phenyl Ethers; Plant Leaves; Prostatic Neoplasms; Taxoids | 2009 |
Growth inhibitory effects of obovatol through induction of apoptotic cell death in prostate and colon cancer by blocking of NF-kappaB.
Topics: Apoptosis; Biphenyl Compounds; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; Humans; Male; NF-kappa B; Phenyl Ethers; Phosphorylation; Prostatic Neoplasms; Tetradecanoylphorbol Acetate; Transcription, Genetic; Tumor Necrosis Factor-alpha | 2008 |